Affiliation:
1. Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
2. University Center of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland
3. Department of Respiratory and Immunology Biologics, AstraZeneca AG, 6340 Baar, Switzerland
4. Medical Faculty, University of Basel, 4056 Basel, Switzerland
Abstract
Emergency care for asthma is provided by general practitioners, pulmonologists, and emergency departments (EDs). Although it is known that patients presenting to EDs with acute asthma exacerbations are a vulnerable population and that this mode of presentation is a risk marker for more severe complications, research on this population is scarce. We conducted a retrospective study on patients with asthma exacerbations who presented to the ED of the University Hospital Basel, Switzerland, during 2017–2020. Of the last 200 presentations, 100 were selected and analyzed to assess demographic information, the use of previous and ED-prescribed asthma medication, and clinical outcomes after a mean period of time of 18 months. Of these 100 asthma patients, 96 were self-presenters, and 43 had the second highest degree of acuity (emergency severity index 2). Global Initiative for Asthma (GINA) step 1 and step 3 were the most common among patients with known GINA levels, accounting for 22 and 18 patients, respectively. A total of 4 patients were undergoing treatment with oral corticosteroids at presentation, and 34 were at discharge. At presentation, 38 patients used the combination therapy of inhaled corticosteroid/long-acting β2-agonist (ICS/LABA), and 6 patients underwent ICS monotherapy. At discharge, 68 patients were prescribed with ICS/LABA. At entry to the ED, about one-third of patients did not use any asthma medication. In total, 10 patients were hospitalized. None of them needed invasive or non-invasive ventilation. A follow-up for the study was precluded by the majority of patients. This group of asthma patients seemed particularly vulnerable as their asthma medication at presentation was often not according to guidelines or even lacking, and almost all the patients had self-presented to the ED without any reference from a physician. The majority of patients did not give consent to the collection of any follow-up information. These medical shortcomings reflect an urgent medical need to improve care for patients at high risk of asthma exacerbations.
Reference33 articles.
1. Global Initiative for Asthma (2022, October 01). Asthma Management and Prevention. Pocket Guide for Health Professionals. Available online: www.ginasthma.org.
2. Global Initiative for Asthma (2022, October 01). Global Strategy for Asthma Management and Prevention. Available online: https://ginasthma.org/wp-content/uploads/2021/05/Whats-new-in-GINA-2021_final_V2.pdf.
3. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: A Cochrane systematic review;Crossingham;BMJ Evid. Based Med.,2022
4. Royal College of Emergency Medicine (2022, October 01). Moderate and Acute Asthma. Clinical Audit 2016/17. Available online: https://rcem.ac.uk/wp-content/uploads/2021/11/Moderate_and_Acute_Severe_Asthma_Clinical_Audit_2016_17.pdf.
5. (2017). Emergency departments are struggling to meet asthma care standards, audit shows. BMJ, 357, j2618.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献